Latest News
Scott Graves has joined Ares Management as a partner in the firm’s private equity group based in Los Angeles.
Graves will lead the Ares Special Situations Funds platform as portfolio manager and head of distressed.
His primary responsibilities will include overseeing investments within the special situations strategy and expanding Ares’ distressed capabilities across the firm. Additionally, Graves will serve as a member of the Ares’ Special Situations and ACOF Investment Committees.
“We have had the pleasure of knowing Scott professionally and personally for the better part of 20 years. Scott has exceptional experience in investing, leading teams and
Alternative Investments Forum (AIF) has appointed veteran institutional investor Melissa Waller as president of its newly formed AIF Institute.
The AIF Institute is the branch of AIF dedicated to educating institutional asset owners about the use of alternative investments such as private equity, private credit, hedge funds, real estate and real assets to achieve their portfolio objectives.
Waller (pictured) joins AIF following her service as deputy treasurer and chief of staff for the North Carolina Department of State Treasurer, where she oversaw strategic planning, operations, policy implementation and a staff of more than 400 employees. The North Carolina Retirement Systems,
Bloomberg BNA has released a new tax management portfolio that focuses on tax considerations for structuring estate planning transactions with carried interests in hedge funds and private equity funds.
The portfolio, Wealth Planning with Hedge Fund and Private Equity Fund Interests and Related Section 2701 Issues, was written by attorneys Todd Angkatavanich, David A Stein and Andrew Haave of Withers Bergman.
The amount of capital under management by private equity and hedge fund managers continues to increase dramatically and, under the current US transfer tax regime, that wealth can be subject to significant taxation either at death or when otherwise
Seedrs, the investment platform backed by Neil Woodford, saw more than GBP85 million invested into campaigns on the platform and 159 deals funded in 2016.
The British fintech company has been live for four-and-a-half years and recently surpassed GBP190 million invested into campaigns with more than 450 deals funded since its launch.
October marked the platform’s biggest ever month with almost GBP20 million invested into campaigns, GBP4.35 million of which was invested into employee and customer engagement provider, Perkbox, becoming Seedrs’ biggest fundraise since launch.
In the same month almost 3,000 Seedrs investors backed peer-to-peer travel money platform,
Omnes Capital is selling its stake in DenyAll to cybersecurity specialist Rohde & Schwarz Cybersecurity.
Omnes Capital has been shareholder in the company alongside Truffle Capital for many years.
It played an active role in its consolidation strategy, which was made concrete with the successive acquisitions of VulnIT in 2012 and BeeWare in 2014.
More particularly, Omnes Capital has encouraged DenyAll’s international expansion. The company has been able to develop its operations in over 30 countries.
DenyAll shares with Rohde & Schwarz Cybersecurity the ambition of creating a European market leader in cybersecurity with an international presence.
Clayton, Dubilier & Rice has appointed Liam FitzGerald, former chief executive officer of UDG Healthcare, as an operating adviser to CD&R funds.
FitzGerald will work out of CD&R’s London office.
As CEO of UDG Healthcare from 2000 until 2016, FitzGerald expanded the business from a mainly Irish-based distribution services business into a multi-faceted and multi-national healthcare services group, operating across 20 countries. During that period, the company’s market capitalisation increased by more than 500 per cent and earnings grew at a compound annual rate of more than 20 per cent.
FitzGerald is credited with leading and integrating more than
Edison Advisors, the investor relations and consulting arm of the Edison Group, has launched a full-service investor relations business to give private and public companies access to its team of analysts and pools of investment capital through its global investor networks.
Established 15 years ago, Edison Investment Research has a team of 80 research analysts producing research across all sectors.
Edison has developed an intelligent distribution platform with analytics capability to identify global investment trends and market dynamics, which it has now evolved for the benefit of investor relations clients.
Rachel Carroll (pictured), global head of investor relations
Tikehau Capital has filed a tender offer with the Autorité des Marchés Financiers (AMF) for the securities of Salvepar, a listed company that focuses on minority investments in listed and non-listed companies.
Tikehau Capital has also initiated a project to reorganise its shareholding structure and governance, as well as those of its consolidated subsidiaries, branches and interests as a whole, in order to prepare for a new phase of development.
As part of this project, Tikehau Capital, which holds 58.8 per cent of the share capital and 59.8 per cent of the voting rights of Salvepar, is filing a
Law firm Proskauer has appointed Stephen Pevsner as a tax partner in the firm’s London office.
“We are delighted to welcome Stephen to the team. He joins us at an exciting time as we continue to enhance our corporate capabilities. Stephen is a leader in tax, with extensive transactional and funds experience, and is a great complement to our tightly integrated offering to asset managers,” says Mary Kuusisto, head of the London office.
Pevsner’s practice focuses on UK and international M&A and private equity transactions, corporate reorganisations, and new business formations. Offering a broad range of corporate tax strategy
Founded to facilitate access to drugs in development for physicians and their patients, myTomorrows has closed a EUR10 million growth funding round co-led by EQT Ventures and Octopus Ventures, with participation from existing investors Balderton Capital and Sofinnova Partners.
Former GlaxoSmithKline chief medical officer James Shannon has also been appointed chairman of the supervisory board.
Currently active in 17 countries, myTomorrows saw there was a problem that needed solving in the way physicians and their patients could access investigational drugs rendering potentially life-saving drugs out of reach. By applying technologies, myTomorrows has built a platform for doctors and patients
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
